4//SEC Filing
Huntsman Carole 4
Accession 0001628280-25-053648
CIK 0001157601other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:39 PM ET
Size
21.7 KB
Accession
0001628280-25-053648
Insider Transaction Report
Form 4
Huntsman Carole
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-11-21$550.97/sh−894$492,567→ 11,096 total - Sale
Common Stock
2025-11-21$548.71/sh−120$65,845→ 10,832 total - Sale
Common Stock
2025-11-21$556.04/sh−120$66,725→ 10,432 total - Sale
Common Stock
2025-11-21$564.57/sh−80$45,165→ 10,032 total - Sale
Common Stock
2025-11-21$553.23/sh−40$22,129→ 10,552 total - Sale
Common Stock
2025-11-21$563.21/sh−40$22,528→ 10,112 total - Sale
Common Stock
2025-11-21$547.27/sh−144$78,807→ 10,952 total - Sale
Common Stock
2025-11-21$559.60/sh−200$111,920→ 10,232 total - Sale
Common Stock
2025-11-21$549.34/sh−40$21,974→ 10,792 total - Sale
Common Stock
2025-11-21$552.38/sh−200$110,477→ 10,592 total - Sale
Common Stock
2025-11-21$560.62/sh−80$44,850→ 10,152 total
Footnotes (11)
- [F1]The sale reported on this line represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $560.24 to $561.00, inclusive.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.55 to $564.58, inclusive.
- [F2]These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.12 to $547.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.25 to $548.94, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.30 to $549.38, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.96 to $552.81, inclusive.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.22 to $553.23, inclusive.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.74 to $556.19, inclusive.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $559.22 to $560.06, inclusive.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0002001571
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:39 PM ET
- Size
- 21.7 KB